A 47-year-old man with Cushingoid appearance was admitted to our hospital showing excessive secretion of cortisol at intervals of a few days. Cyclic Cushing's disease was confirmed. Two years earlier, results of hormonal assessment had been within normal limits and macroadenoma had been incidentally detected in the pituitary. Dexamethasone suppression testing revealed various responses and a small lung tumor was detected, therefore his condition was misinterpreted as ectopic ACTH-producing tumor or pituitary cyclical Cushing's disease, leading to lung resection that confirmed cryptococcal pneumonia. The pituitary tumor was finally identified as the cause of cyclic Cushing's syndrome and fully removed, allowing remission.
Introduction
Cyclic Cushing's disease is difficult to diagnose because levels of ACTH and cortisol alternate between normal and high, the former situation occurring in episodes lasting from a few days to years (1) . Most reported causes of this disease involve pituitary adenoma or occasionally ectopic ACTHproducing tumor, with variable results of endocrine function tests incompatible with simple pituitary or ectopic Cushing's disease. Diagnosis allowing surgical treatment to achieve remission in patients with this disease can thus be troublesome.
Cryptococcal pneumonia usually occurs in immunocompromised patients and excess cortisol production can theoretically produce a state of immunodeficiency. Development of cryptococcal pneumonia concomitant with Cushing's disease has been reported, but concomitant development of cyclic Cushing's disease has not (2) . Here, we report a case of pituitary cyclic Cushing's disease revealed by various cortisol responses to dexamethasone suppression testing and confused with ectopic ACTH-producing tumor. Cryptococcal pneumonia was diagnosed following lung resection and a pituitary tumor was finally identified as the cause of pituitary cyclic Cushing's syndrome and fully removed, allowing remission. tory results at that time revealed high levels of plasma ACTH and hypercortisolism (Table 1) . These findings seemed compatible with Cushing's syndrome and admission was arranged.
On admission, the patient was 170 cm tall and weighed 68 kg. Blood pressure was 146/86 mmHg under treatment with hypotensive drugs and heart rate was 108 beats/min. His eyelids were edematous, his face was rounded and he also showed central obesity.
After admission, excessive secretion of ACTH and cortisol were seen at intervals of a few days, with active and inactive phases. Overnight dexamethasone suppression tests (1 mg and 8 mg) on May 30, 31, suppressed plasma cortisol levels to 4.7 μg/dL and 5.1 μg/dL, respectively, compatible with pituitary Cushing's disease (Table 2) .
Daily cortisol profile on June 7 showed that the cortisol level was not suppressed at night and a subsequent dexamethasone overnight 1-mg suppression test revealed paradoxical elevation to 33.1 μg/dL the next morning ( Table 2) . Reexamination of the cortisol daily profile on June 15 showed that the cortisol level was suppressed to <5 μg/dL at night and a dexamethasone overnight 8-mg suppression test on August 1 revealed a paradoxical elevation to 41.9 μg/dL the next morning (Table 2 ). Daily urinary free cortisol (UFC) levels ranged between 32 and 8,420 μg/day and in mid-June UFC was 3,200 μg/day (active phase) ( Table 2) . A corticotropin-releasing hormone (CRH) stimulation test was performed. After CRH stimulation, basal/peak plasma ACTH and serum cortisol levels were normal at 18/69 pg/mL for ACTH (30 minutes) and 3.8/19.3 μg/dL for serum cortisol (60 minutes).
MRI revealed macroadenoma on the left side of the pituitary with internal bleeding, identified as an area of highintensity on T1-weighted imaging, intense enhancement after gadolinium (Gd) administration and high-intensity on T2-weighted imaging (Fig. 1C, D) . The pituitary macroadenoma was seen to have been slightly smaller on the MRI performed 1 year earlier in the absence of Cushingoid symptoms.
We performed cavernous sinus venous sampling (CSS) in early June, which revealed higher ACTH levels in the right cavernous sinus (91 pg/ml) compared to peripheral venous blood (18 pg/mL; ratio, 5.1), while CRH stimulation showed higher ACTH levels in the right cavernous sinus (311 pg/ mL) than in periphery blood (18 pg/mL; ratio, 17.2) (Table 3).
Positron emission tomography (PET) using 18 F-2-fluorodeoxyglucose (FDG) was performed to examine the possibility of an ectopic ACTH-producing tumor; it revealed abnormal FDG uptake in the left upper lung ( Fig. 2A) . Chest computed tomography (CT) was therefore performed and detected a small tumor in the same region (Fig. 2B) . Although that tumor had not been detected radiographically on admission, the possibility of ACTH-producing lung cancer had to be excluded. Needle biopsy under CT was performed to allow histopathological confirmation, but the specimen was insufficient to allow a definitive diagnosis. Partial lung resection under video-assisted thoracic surgery (VATS) was performed, revealing cryptococcal pneumonia (Fig. 2C) . Fluconazole therapy (200 mg/day) was instituted from July 21 to prevent dissemination and administration of sulfamethoxazole-trimethoprim was started to prevent pneumocystis pneumonia.
A diagnosis of cyclic pituitary Cushing's disease due to pituitary adenoma was considered compatible with the observed findings, therefore transsphenoidal adenectomy was performed. Histopathological examination revealed pituitary adenoma with sparse staining of ACTH-immunopositive cells throughout the tumor (Fig. 2D, E) . Postoperative plasma ACTH and cortisol levels fell to below the level of Urinary free cortisol of 24 hours was measured at 10:00
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Discussion
Cyclic Cushing's disease is a rare disorder that can prove difficult to diagnose, because the excessive secretion of ACTH and cortisol occurs periodically at intervals ranging from a few days to years, interspersed by periods of normal cortisol secretion, as the so-called "inactive phase". Secretion cycles can occur regularly or irregularly. The switch to excessive production of ACTH and cortisol in the "active phase" can occur unexpectedly. The origins of this disease are most often reported as pituitary adenoma (54%), followed by ectopic ACTH-producing tumor (26%). The pathophysiology of cyclic Cushing's disease remains largely unknown (1).
In pituitary cyclic Cushing's disease, the results of endocrine function testing are variable and incompatible with pituitary Cushing's disease. The results of such tests may differ depending on whether the patient is in the active or inactive phase. In the present case, overnight 1-mg and 8-mg dexamethasone suppression tests revealed that plasma ACTH and cortisol levels were not suppressed in the inactive phase, and plasma ACTH and cortisol levels were excessively elevated in the active phase as indicated by UFC. This represents the so-called "paradoxical response" to dexamethasone (3) (4) (5) , and has been reported with ectopic ACTHproducing tumors (6, 7) . These results in the present case may have merely been coincidental with periods of increased endogenous tumor activity (5) . Apoptosis of ACTHproducing cells induced by dexamethasone was considered as a possibility, given that glucocorticoid apoptosis is an established phenomenon in various cell lines (8, 9) . The present case showed daily cortisol levels that were not particularly high, but daily UFC on the same day showed excessively high levels. In our hospital, UFC concentration was calculated for 24 hours from 10:00. The interval of cortisol secretion may have been very short in our case, so the inconstant paradoxical dexamethasone response can be explained by the presence of spontaneous rhythm with periodic increases. As a result, dexamethasone suppression tests may not be particularly useful in the short-term analysis of cyclic Cushing's disease.
The desmopressin stimulation test is useful to diagnose whether the patient is in the active or inactive phase in cyclic Cushing's disease. Sakai et al. reported that ACTH shows a response to desmopressin only in the active phase (10) . In the present case, no desmopressin stimulation test was performed.
CSS after CRH administration is accurate for distinguishing patients with pituitary Cushing's disease from those with the ectopic ACTH syndrome (11) . In the present case, CSS was probably performed in the inactive phase, given the low peripheral ACTH level. In other reported cases of cyclic Cushing's disease, 6 of the 10 cases for which CSS was performed showed positive findings. Of these, 5 cases underwent CSS in the active phase, and 1 case underwent CSS in the non-active phase. In addition, in 2 cases, positive findings were not obtained even in the active case. Therefore, in pituitary cyclic Cushing's disease, successful identification of ACTH production from a pituitary adenoma using only CSS can be very difficult (12) . A previous report described selective venous sampling in the inactive phase and MRI detection of microadenoma on the opposite side of what would have been expected based on endocrinological results for CSS (13) . Following hypophysectomy in that case, no hyperplastic corticotrophic cells were revealed in the pituitary. Given such findings, the CSS study result in the present case may have been compatible with pituitary Cushing's disease, but it was unreliable because the ACTH level appeared high on the opposite side of the pituitary adenoma.
In the present case, responses of ACTH to intravenous administration of CRH were probably examined in the inactive phase. In pituitary Cushing's disease, ACTH shows a blunted response to CRH, whereas ectopic Cushing's disease shows no response to CRH. In cases of ectopic ACTHproducing tumor in the inactive phase, CRH stimulation testing may show a normal response pattern, so this test is not useful for detecting cyclical ACTH-producing lesions.
A concomitant small lung tumor was erroneously suspected as representing ectopic ACTH-producing tumor, but it was finally diagnosed as cryptococcal pneumonia after partial lung resection under VATS. The patient showed exaggerated serum cortisol levels in a cyclical manner, and therefore remained immunocompetent while suffering from concomitant cryptococcal pneumonia. Immunocompetent patients with cryptococcal pneumonia are typically asymptomatic and the pathology is thus rarely fatal, whereas cryptococcal disease in immunosuppressed patients is frequently fatal and will disseminate widely, particularly in patients compromised by human immunodeficiency virus. Although serum and urine cortisol levels were not always excessive in the present case, the patient developed cryptococcal pneumonia. In Cushing's syndrome, ectopic production of ACTH means that thresholds for identifying severe infection are a serum cortisol level of!43.1 μg/dL and a UFC level of! 2,000 μg/day (14) , and plasma cortisol levels of 121 μg/dL may allow discrimination of cryptococcosis (15) . Sakihara et al. reported that high cortisol levels (>5 μg/ dL) and UFC late at night are useful for diagnosing Cushing's disease (16) . In cases with periodic production of ACTH and cortisol, cortisol levels late at night may be normal in the inactive phase and the diagnosis may be missed. In the present case, the cortisol level was actually 4.7 μg/dL at 22:00 in mid-June.
In cyclic Cushing's disease, cyproheptadine has been reported to abate cyclical excessive ACTH production (17) . In this case, cyproheptadine treatment was administrated, but serum cortisol level was not suppressed and the patient was considered to have been in a compromised state. Cyclic Cushing's disease has been reported in association with pituitary stones (18) , repeated calcification of infarcted neoplastic tissue and persistence of negative feedback control for tumoral ACTH secretion by cortisol (1). We speculate that the cause of pituitary cyclic Cushing's disease in the present case was as follows. First, a process of metamorphosis occurred from the non-functional pituitary adenoma seen in 2005, to functional pituitary adenoma. A case of progression from non-functioning pituitary adenoma to pituitary Cushing's disease has been reported previously (19) . The reason for the cyclical rhythm to ACTH production remains unclear. MRI in 2005 had revealed suspected tumor hemorrhage in a pituitary adenoma and the fact that the pituitary macroadenoma had been smaller in 2007 may suggest repeated hemorrhage or necrosis leading to tumor size involution. Repeated hemorrhage or necrosis in adenoma may be causes of cyclical ACTH production.
In summary, we have reported a case of pituitary cyclic Cushing's disease with variable cortisol responses to dexamethasone suppression tests in the active and inactive phases. This condition was misinterpreted as ectopic ACTHproducing lung tumor rather than pituitary cyclical Cushing's disease, leading to lung resection that confirmed cryptococcal pneumonia. The pituitary tumor was eventually fully removed and cyclical cortisol secretion was completely resolved.
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